Skip to main content

Table 3 Changes in median expression and corresponding null probability values () for pair-wise comparison of disease classes and the non-fatigued control group under both classification systems

From: Evidence of inflammatory immune signaling in chronic fatigue syndrome: A pilot study of gene expression in peripheral blood

   

3-Class (NF Controls)

7-Class (Controls = LCA-0 U LCA-2)

Cell Type

Expression Level +/-

Number of genes

ISF

CFS

LCA-1

LCA-3

LCA-4

LCA-5

LCA-6

CD8 T cells

Up-regulated

5

0.06 (0.43)

0.01 (0.75)

0.06 (0.52)

0.00 (0.64)

0.04 (0.24)

0.01 (0.80)

0.23 (0.27)

 

Down-regulated

        

CD14 Monocytes

Up-regulated

78

0.04 (0.29)

0.05 (0.83)

0.02 (0.62)

0.11 (0.15)

0.09 (0.42)

0.02 (0.94)

0.05 (0.33)

 

Down-regulated

        

CD16 Neutrophils

Up-regulated

        
 

Down-regulated

185

0.02 (0.20)

0.02 (0.25)

0.02 (0.29)

0.00 (0.65)

0.03 (0.25)

0.02 (0.50)

0.04 (0.30)

CD19 B cells

Up-regulated

6

-0.17 (0.05)

-0.28 (0.01)

-0.27 (0.29)

-0.31 (0.04)

-0.12 (0.13)

-0.25 (0.09)

-0.17 (0.14)

 

Down-regulated

2

-0.22 (0.33)

-0.22 (0.29)

-0.18 (0.19)

0.07 (0.71)

0.10 (0.76)

-0.08 (0.78)

-0.08 (0.16)

CD4/8/25 T reg cells

NA

1

-0.23 (0.19)

-0.23 (0.31)

-0.35 (0.09)

0.19 (0.37)

-0.25 (0.11)

-0.17 (0.32)

0.28 (0.40)

NK cells

NA

4

0.09 (0.92)

0.30 (0.07)

0.19 (0.20)

0.32 (0.11)

0.12 (0.68)

0.12 (0.45)

-0.01 (0.57)